The EveryLife Foundation for Rare Diseases is accepting applications for a scholarship program that aims to help adults with a…
Articles by Patricia Inacio, PhD
Research into the potential interplay between different immune system components and coagulation in patients with ANCA-associated vasculitis (AAV), COVID-19 and …
The majority of people with ANCA-associated vasculitis (AAV) and other forms of vasculitis plan to get the COVID-19 vaccine,…
InflaRx has completed enrollment in its Phase 2 trial evaluating vilobelimab (IFX-1) for people with…
Patient dosing has begun in a Phase 3 clinical trial investigating the asthma treatment Fasenra (benralizumab) in people with…
ChemoCentryx is planning to file a request with the U.S. Food and Drug Administration (FDA) by mid-year seeking approval of…
Outcomes for people with ANCA-associated vasculitis (AAV) who have an alveolar hemorrhage (bleeding in the lungs’ air sacs) are likely…
The number of treatments for children with rare diseases has grown over the past decade, according to a new study. However,…
Patients with granulomatosis with polyangiitis, a subtype of ANCA-associated vasculitis (AAV), have a higher rate of hospitalizations than the…
High-dose glucocorticoids — a type of corticosteroid hormone — are commonly prescribed as part of remission-induction therapy to people…